Phoenix Holdings Ltd. Sarepta Therapeutics, Inc. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$72.25 - $168.95 $95,875 - $224,196	-1,327 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $166,618 - $237,187	1,327 New	1,327 $227,000
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $8.11 Million - $15 Million	-87,178 Closed	0 $0
Q1 2020 May 20, 2020	BUY	$82.38 - $131.64 $823,800 - $1.32 Million	10,000 Added 12.96%	87,178 $8.33 Million
Q4 2019 Feb 18, 2020	SELL	$76.53 - $135.58 $807,468 - $1.43 Million	-10,551 Reduced 12.03%	77,178 $9.89 Million
Q3 2019 Nov 18, 2019	BUY	$72.81 - $156.91 $6.39 Million - $13.8 Million	87,729 New	87,729 $6.3 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.